131
Participants
Start Date
August 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
January 31, 2010
Standard Bicarbonate Solution
Patients received 0 micrograms (µg) of iron/ decilited (dL) of dialysate during dialysis 3 times/week for up to 26 weeks.
Soluble Ferric Pyrophosphate
Patients received 5 micrograms (µg) of iron/ decilited (dL) of dialysate during dialysis 3 times/week for up to 26 weeks.
Soluble Ferric Pyrophosphate
Patients received 10 micrograms (µg) of iron/ decilited (dL) of dialysate during dialysis 3 times/week for up to 26 weeks.
Soluble Ferric Pyrophosphate
Patients received 12 micrograms (µg) of iron/ decilited (dL) of dialysate during dialysis 3 times/week for up to 26 weeks.
Soluble Ferric Pyrophosphate
Patients received 15 micrograms (µg) of iron/ decilited (dL) of dialysate during dialysis 3 times/week for up to 26 weeks.
Investigator, New York
Investigator, Great Neck
Investigator, Brooklyn
Investigator, Ridgewood
Investigator, Mineola
Investigative Site, Hershey
Investigator, Arlington
Investigator, Winston-Salem
Investigative Site, Augusta
Investigative Site, Canton
Investigator, Cincinnati
Investigative Site, Detroit
Investigator, Chicago
Investigator, New Orleans
Investigator, Arlington
Investigator, Fort Worth
Investigator, San Antonio
Investigator, McAllen
Investigator, Meridian
Investigator, Tempe
Investigator, Los Angeles
Investigator, Whittier
Investigator, Hacienda Heights
Investigator, Seattle
Investigative Site, Louisville
Investigator, Springfield
Investigator, Hackensack
Investigative Site, Edmonton
Rockwell Medical Technologies, Inc.
INDUSTRY